Advances in the treatment of lung cancer and melanoma

Roundup of the EMCC 2011 conference

Affordable cancer care in high-income countries

Experimenting with smaller, faster clinical trials

Denosumab delays metastases for prostate cancer

Trastuzumab emtansine, Phase II trial for HER2

Cost effective ways to predict prostate cancer 1/2

Cost effective ways to predict prostate cancer 2/2

ecancerhub past, present and future

Guidelines and recommendations for advanced melanoma (5/6)

Combination of newer agents in advanced melanoma (4/6)

Recent advances in advanced melanoma: BRAF inhibitors (3/6)